Bolt Biotherapeutics Inc (BOLT)

$6.00 +0.24 (4.17%)
Market Cap 11.06M
Revenue (ttm) 7.69M
Net Income (ttm) -63.12M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -820.81%
Debt to Equity Ratio 0.00
Volume 10,100
Avg Vol 23,362
Day's Range N/A - N/A
Shares Out 1.92M
Stochastic %K 53%
Beta 0.91
Analysts Sell
Price Target $6.50

Company Profile

Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer. The company dBDC-3042, develops dan agonist antibody targeting Dectin-2 for range of tumors, such as head and neck, non-small cell lung, ovarian, triple-negative breast, and other cancer; and BDC-4182, an next-generation boltbody technology platform that targets claudin 18.2, which is overexpressed in gastric/gastroesophageal junction cancer, pancreat...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 665 9295
Address:
900 Chesapeake Drive, Redwood City, United States
skyrockets_Inc
skyrockets_Inc Oct. 24 at 7:25 PM
$BOLT Update to chart. Still holding 100 and 50 day SMA with solid support. $15/share in cash. 0 debt. Low float 1.92m shares. 40% institutional ownership w/ TANG owning 8%. BDC-4182 in clinical trials and BDC-3042 in partnering search process. Still maintaining ISAC collaborations w/ big pharma partners Genmab and Toray. Easy buyout candidate at these levels. I'm buying more. Next week should be fire. Low float biotechs have been hot lately. Just looks at what $NERV and $GLTO did recently.
0 · Reply
skyrockets_Inc
skyrockets_Inc Oct. 21 at 6:33 PM
$BOLT Looking real good. Holding strong above the 100SMA. Volume steadily increasing the past 30 days. Something is coming soon imo. $NERV did it today as I mentioned before. Same w/ $GLTO. 2 for 2. $BOLT is next.
0 · Reply
rp6577
rp6577 Oct. 20 at 7:17 PM
$BOLT chart looking good
0 · Reply
skyrockets_Inc
skyrockets_Inc Oct. 20 at 5:07 PM
$BOLT H.C. Wainright initiates coverage w/ a $7/share PT . They know. $15/share in cash and only ~1.92m shares OS. With minimal cash burn this will moon soon.
0 · Reply
notreload_ai
notreload_ai Oct. 20 at 3:57 PM
$BOLT , $NAMS ... H.C. Wainwright initiates coverage on Bolt Biotherapeutics and NewAmsterdam Pharma with Buy ratings, highlighting innovative treatments in development. https://notreload.xyz/bolt-bio-newamsterdam-get-hc-wainwright-buy-ratings/
0 · Reply
JarvisFlow
JarvisFlow Oct. 20 at 10:43 AM
HC Wainwright & Co. updates rating for Bolt Biotherapeutics ( $BOLT ) to Buy, target set at 7.
0 · Reply
BetterDayzz
BetterDayzz Oct. 16 at 4:31 AM
$BOLT Very bullish set-up. Our time is coming soon
0 · Reply
skyrockets_Inc
skyrockets_Inc Oct. 15 at 5:02 PM
$BOLT Am I really a crazy person here? Is no one else seeing this obvious set up for a huge lift off? Stabilizing above the 50 and 100 SMA w/ lots of consistent volume the past 3 weeks. If this doesn't launch to the stratosphere soon I'll be shocked. I was right on $GLTO and on $NERV afterwards. This is the obvious next w/ only 1.92m shares OS. Get in while you still can. Float is thin and very illiquid.
0 · Reply
skyrockets_Inc
skyrockets_Inc Oct. 14 at 5:08 PM
$BOLT when they finally let this fly it's going to be epic
0 · Reply
MilsLearning
MilsLearning Oct. 13 at 9:01 AM
$BOLT "L"ets "F" "S"horts 🩳🔥🩳🔥🖕🔥🩳🔥🕖🔜✅ Ever get bullied??? Trading stocks?? Me too!!! Get the bullies out of the schools 🏫 The IPO Foreign Meme movement ***LFS***🩳🔥
0 · Reply
Latest News on BOLT
Bolt Biotherapeutics Provides Update on BDC-4182 and Extends Cash Runway into 2027

Oct 1, 2025, 4:05 PM EDT - 24 days ago

Bolt Biotherapeutics Provides Update on BDC-4182 and Extends Cash Runway into 2027

Bolt Biotherapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update

Aug 14, 2025, 4:05 PM EDT - 2 months ago

Bolt Biotherapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update

Bolt Biotherapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

May 12, 2025, 4:05 PM EDT - 5 months ago

Bolt Biotherapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

Bolt Biotherapeutics to Host KOL Conference Call and Webcast to Discuss BDC-3042 Phase 1 Results and Corporate Updates

May 8, 2025, 8:00 AM EDT - 6 months ago

Bolt Biotherapeutics to Host KOL Conference Call and Webcast to Discuss BDC-3042 Phase 1 Results and Corporate Updates

Bolt Biotherapeutics Presents Preclinical Results for Next-Generation Boltbody™ ISACs targeting CEA and PD-L1 at AACR Annual Meeting 2025

Apr 30, 2025, 4:05 PM EDT - 6 months ago

Bolt Biotherapeutics Presents Preclinical Results for Next-Generation Boltbody™ ISACs targeting CEA and PD-L1 at AACR Annual Meeting 2025

Bolt Biotherapeutics Presents Results from the Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025

Apr 25, 2025, 1:00 PM EDT - 6 months ago

Bolt Biotherapeutics Presents Results from the Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025

Bolt Biotherapeutics to Present Data from Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025

Mar 25, 2025, 4:30 PM EDT - 7 months ago

Bolt Biotherapeutics to Present Data from Phase 1 Dose-Escalation Clinical Study of BDC-3042 at AACR Annual Meeting 2025

Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update

Mar 24, 2025, 4:20 PM EDT - 7 months ago

Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides Business Update

Bolt Biotherapeutics to Participate in Upcoming March Conferences

Feb 25, 2025, 4:05 PM EST - 8 months ago

Bolt Biotherapeutics to Participate in Upcoming March Conferences

Bolt Biotherapeutics, Inc. Provides Update on Global Cancer Immunotherapy Co-Development with Toray Industries, Inc.

Feb 11, 2025, 4:05 PM EST - 9 months ago

Bolt Biotherapeutics, Inc. Provides Update on Global Cancer Immunotherapy Co-Development with Toray Industries, Inc.

Bolt Biotherapeutics Presents Updated Preclinical Data for BDC-4182 and Key Learnings from Phase 1 Dose-Escalation Trial of BDC-1001 at SITC 39th Annual Meeting

Nov 7, 2024, 10:00 AM EST - 1 year ago

Bolt Biotherapeutics Presents Updated Preclinical Data for BDC-4182 and Key Learnings from Phase 1 Dose-Escalation Trial of BDC-1001 at SITC 39th Annual Meeting

Bolt Biotherapeutics, Inc. May Have Violated Securities Laws And Shareholders Are Urged To Participate In A Case With The Schall Law Firm

Sep 6, 2024, 11:00 AM EDT - 1 year ago

Bolt Biotherapeutics, Inc. May Have Violated Securities Laws And Shareholders Are Urged To Participate In A Case With The Schall Law Firm

Bolt Biotherapeutics Announces Changes to its Board of Directors

Sep 4, 2024, 4:05 PM EDT - 1 year ago

Bolt Biotherapeutics Announces Changes to its Board of Directors

Bolt Biotherapeutics Inc. May Have Violated Securities Regulations And Stakeholders Are Urged To Reach Out To The Schall Law Firm

Sep 4, 2024, 11:00 AM EDT - 1 year ago

Bolt Biotherapeutics Inc. May Have Violated Securities Regulations And Stakeholders Are Urged To Reach Out To The Schall Law Firm

BOLT Deadline: Rosen Law Firm Urges Bolt Biotherapeutics, Inc. (NASDAQ: BOLT) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

Sep 2, 2024, 11:11 AM EDT - 1 year ago

BOLT Deadline: Rosen Law Firm Urges Bolt Biotherapeutics, Inc. (NASDAQ: BOLT) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

Stakeholders Can Contact The Schall Law Firm About Joining A Case Against Bolt Biotherapeutics Inc. For Securities Law Infractions

Sep 2, 2024, 11:00 AM EDT - 1 year ago

Stakeholders Can Contact The Schall Law Firm About Joining A Case Against Bolt Biotherapeutics Inc. For Securities Law Infractions

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Bolt

Aug 31, 2024, 11:25 AM EDT - 1 year ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Bolt

Bolt Biotherapeutics Inc. Is Being Sued For Possibly Engaging In Securities Related Infractions And Shareholders Can Assist The Schall Law Firm

Aug 31, 2024, 11:00 AM EDT - 1 year ago

Bolt Biotherapeutics Inc. Is Being Sued For Possibly Engaging In Securities Related Infractions And Shareholders Can Assist The Schall Law Firm

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Bolt

Aug 29, 2024, 8:49 PM EDT - 1 year ago

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Bolt

The Schall Law Firm Urges Investors To Join A Lawsuit For Securities Fraud Against Bolt Biotherapeutics Inc

Aug 28, 2024, 11:00 AM EDT - 1 year ago

The Schall Law Firm Urges Investors To Join A Lawsuit For Securities Fraud Against Bolt Biotherapeutics Inc

A Case Has Been Filed Against Bolt Biotherapeutics Inc For Securities Law Infractions And Stakeholders Are Encouraged To Contact The Schall Law Firm

Aug 27, 2024, 11:00 AM EDT - 1 year ago

A Case Has Been Filed Against Bolt Biotherapeutics Inc For Securities Law Infractions And Stakeholders Are Encouraged To Contact The Schall Law Firm

Bolt Biotherapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

Aug 13, 2024, 4:05 PM EDT - 1 year ago

Bolt Biotherapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update

BOLT Investors Have Opportunity to Actively Participate Bolt Biotherapeutics, Inc.

Jul 26, 2024, 10:00 AM EDT - 1 year ago

BOLT Investors Have Opportunity to Actively Participate Bolt Biotherapeutics, Inc.

BOLT Investors Have Opportunity to Lead Bolt Biotherapeutics, Inc.

Jul 25, 2024, 10:00 AM EDT - 1 year ago

BOLT Investors Have Opportunity to Lead Bolt Biotherapeutics, Inc.

Faruqi & Faruqi LLP Reminds Shareholders of a Lead Plaintiff Deadline on September 3, 2024 in Bolt Lawsuit

Jul 19, 2024, 11:10 AM EDT - 1 year ago

Faruqi & Faruqi LLP Reminds Shareholders of a Lead Plaintiff Deadline on September 3, 2024 in Bolt Lawsuit

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Bolt Biotherapeutics, Inc. (BOLT)

Jul 3, 2024, 4:47 PM EDT - 1 year ago

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Bolt Biotherapeutics, Inc. (BOLT)

Bolt Biotherapeutics, Inc. Investors: Company Investigated by the Portnoy Law Firm

Jun 24, 2024, 3:36 PM EDT - 1 year ago

Bolt Biotherapeutics, Inc. Investors: Company Investigated by the Portnoy Law Firm

Bolt Biotherapeutics, Inc. (BOLT) Q1 2024 Earnings Call Transcript

May 17, 2024, 8:37 PM EDT - 1 year ago

Bolt Biotherapeutics, Inc. (BOLT) Q1 2024 Earnings Call Transcript

skyrockets_Inc
skyrockets_Inc Oct. 24 at 7:25 PM
$BOLT Update to chart. Still holding 100 and 50 day SMA with solid support. $15/share in cash. 0 debt. Low float 1.92m shares. 40% institutional ownership w/ TANG owning 8%. BDC-4182 in clinical trials and BDC-3042 in partnering search process. Still maintaining ISAC collaborations w/ big pharma partners Genmab and Toray. Easy buyout candidate at these levels. I'm buying more. Next week should be fire. Low float biotechs have been hot lately. Just looks at what $NERV and $GLTO did recently.
0 · Reply
skyrockets_Inc
skyrockets_Inc Oct. 21 at 6:33 PM
$BOLT Looking real good. Holding strong above the 100SMA. Volume steadily increasing the past 30 days. Something is coming soon imo. $NERV did it today as I mentioned before. Same w/ $GLTO. 2 for 2. $BOLT is next.
0 · Reply
rp6577
rp6577 Oct. 20 at 7:17 PM
$BOLT chart looking good
0 · Reply
skyrockets_Inc
skyrockets_Inc Oct. 20 at 5:07 PM
$BOLT H.C. Wainright initiates coverage w/ a $7/share PT . They know. $15/share in cash and only ~1.92m shares OS. With minimal cash burn this will moon soon.
0 · Reply
notreload_ai
notreload_ai Oct. 20 at 3:57 PM
$BOLT , $NAMS ... H.C. Wainwright initiates coverage on Bolt Biotherapeutics and NewAmsterdam Pharma with Buy ratings, highlighting innovative treatments in development. https://notreload.xyz/bolt-bio-newamsterdam-get-hc-wainwright-buy-ratings/
0 · Reply
JarvisFlow
JarvisFlow Oct. 20 at 10:43 AM
HC Wainwright & Co. updates rating for Bolt Biotherapeutics ( $BOLT ) to Buy, target set at 7.
0 · Reply
BetterDayzz
BetterDayzz Oct. 16 at 4:31 AM
$BOLT Very bullish set-up. Our time is coming soon
0 · Reply
skyrockets_Inc
skyrockets_Inc Oct. 15 at 5:02 PM
$BOLT Am I really a crazy person here? Is no one else seeing this obvious set up for a huge lift off? Stabilizing above the 50 and 100 SMA w/ lots of consistent volume the past 3 weeks. If this doesn't launch to the stratosphere soon I'll be shocked. I was right on $GLTO and on $NERV afterwards. This is the obvious next w/ only 1.92m shares OS. Get in while you still can. Float is thin and very illiquid.
0 · Reply
skyrockets_Inc
skyrockets_Inc Oct. 14 at 5:08 PM
$BOLT when they finally let this fly it's going to be epic
0 · Reply
MilsLearning
MilsLearning Oct. 13 at 9:01 AM
$BOLT "L"ets "F" "S"horts 🩳🔥🩳🔥🖕🔥🩳🔥🕖🔜✅ Ever get bullied??? Trading stocks?? Me too!!! Get the bullies out of the schools 🏫 The IPO Foreign Meme movement ***LFS***🩳🔥
0 · Reply
skyrockets_Inc
skyrockets_Inc Oct. 10 at 4:16 PM
$BOLT Blood red day across the board. But w/ $BOLT just set it and forget it.
0 · Reply
_CircuitBreaker
_CircuitBreaker Oct. 9 at 10:43 PM
Keep a close watch on CMCT! ITS MOVING!! $HUSA $DUO $BOLT $AEMD /
1 · Reply
_CircuitBreaker
_CircuitBreaker Oct. 9 at 8:47 PM
Keep a close watch on CMCT! $CLRO $BOLT $ARBB $TAOP 222
0 · Reply
skyrockets_Inc
skyrockets_Inc Oct. 9 at 6:08 PM
$BOLT first was $GLTO, then $NERV, next $BOLT on the low float action ~1.92m OS, $15/share in cash, 30% institutional ownership w/ 5% insider ownership. Tang owns 10% . BDC-3142 data due in Q3 2026 and partnership announcement possibility for BDC-3042 anytime before then. Loading has been happening consistently the past ~2 weeks can see it in the volume chart.
1 · Reply
skyrockets_Inc
skyrockets_Inc Oct. 8 at 3:23 PM
$BOLT front loading appears to continue. volume picking up. looking good.
0 · Reply
skyrockets_Inc
skyrockets_Inc Oct. 8 at 12:16 PM
$BOLT Buckle up and $BOLT in
0 · Reply
rp6577
rp6577 Oct. 8 at 11:04 AM
$BOLT could get spicy today 🔥 a lot of cash starting to come into bios. Could see some further big runners
0 · Reply
onemillion2012
onemillion2012 Oct. 8 at 6:33 AM
$BCAB the setup last 3 weeks. Speak for it self.. We are going to Dollarland. The company have stated that "share price will cure itself". And no toxic capital raise. It is a screaming buy.. but as usual no one knows this stock. Just like my other undervalued 💎. Like $ASMB and $BOLT and then we have a well known company like $CROX with very low p/e and if you don't like consumer. Then look at $ALIT HR software with five percent dividend. Just crazy. When you think of shitty stocks that 10fold over night..
0 · Reply
CocaKolla
CocaKolla Oct. 7 at 11:20 PM
$BOLT keep eye 👁
1 · Reply
CombineSoldeir
CombineSoldeir Oct. 7 at 8:28 PM
$BOLT
0 · Reply
IbBeltran
IbBeltran Oct. 7 at 7:46 PM
$BOLT NXXT textbook grind from 2.26 low to 2.82 close higher lows every hour RSI 60 to 62 momentum friendly expecting 2.83 to flip to support and send to 3.20 volume 5.7M confirms
0 · Reply
BetterDayzz
BetterDayzz Oct. 7 at 6:56 PM
$BOLT Expecting big things ⏰
0 · Reply